Probe Into Amedisys Concludes With No SEC Action

A four-year Securities and Exchange Commission (SEC) investigation into one of the nation’s leading home health care companies has concluded, and SEC says it will take no further action against the provider. SEC staff recently advised Amedisys, Inc. (Nasdaq:AMED) that the investigation by the SEC related to the company’s operations and participation in the Medicare program […]

Gentiva Rejects Kindred Offer, Again

Gentiva Health Services (NASDAQ:GTIV) has rejected Kindred Healthcare’s (NYSE:KND) latest bid to buy the company, saying it significantly undervalues Gentiva and is not in the best interests of its shareholders.  In the most recent bid, Kindred offered to acquire all outstanding shares of Gentiva’s common stock for $14.50 per share, making the deal a $1.7 billion acquisition. […]

Kindred to Gentiva: Don’t Acquire Amedisys

In the latest move of Kindred Healthcare’s ongoing quest to buy Gentiva Health Services, Kindred (NYSE:KND) has sent a letter to the Gentiva (NASDAQ:GTIV) board of directors, telling the company to reconsider its pursuits of acquiring Amedisys Inc. (NASDAQ:AMED). The acquisition, Kindred writes, would disenfranchise Gentiva shareholders. Instead, Kindred urges the board to discuss its “highly […]

Amedisys Proposes Settlement Resolving Insider Trading Suit

A proposed settlement resolving a civil lawsuit accusing home health and hospice company Amedisys, Inc. (NASDAQ:AMED) of insider trading has been preliminarily approved by the United States District Court for the Middle District of Louisiana. Shareholders filed a federal lawsuit, Robert F. Bach, et al., v Amedisys, Inc., et all., against Amedisys alleging that some of […]

Managed Care Shift Will Halve Home Health Revenues for Amedisys from Humana

Home health and hospice care provider Amedisys, Inc. (NASDAQ:AMED) will see a diminished annual revenue after signing a new agreement with Humana Inc. (NYSE:HUM) regarding how it will be reimbursed for home health services provided. Under the new agreement, which reflects a national shift toward managed care, Amedisys will be paid on a per-visit basis. […]